9,10-dimethyl-1,2-benzanthracene has been researched along with toremifene in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 9 (69.23) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| di Salle, E; Ornati, G; Zaccheo, T | 1 |
| Grönroos, M; Kangas, L | 1 |
| Cantell, K; Kangas, L; Schellekens, H | 1 |
| Kangas, L | 1 |
| Haaparanta, M; Kangas, L; Paul, R; Roeda, D; Sipilä, H | 1 |
| Alitalo, K; Sandberg, M; Vuorio, E; Vuorio, T; Wärri, A | 1 |
| Jordan, VC; Mauel, DA; Robinson, SP | 1 |
| Alanen, KA; Collan, YU; Huovinen, RL | 1 |
| Collan, Y; Huovinen, R; Kellokumpu-Lehtinen, PL | 1 |
| Collan, Y; Huovinen, R | 1 |
| Ala-Uotila, S; Jaakkola, UM; Lähde, M; Pyykkö, K | 1 |
| Collan, Y; Huovinen, R; Wärri, A | 1 |
| Cockcroft, N; Dahllund, J; Härkönen, P; Hemminki, K; Kangas, L; Koskinen, M; Laine, A; Peng, Z; Qu, Q; Väänänen, K; Zheng, H | 1 |
13 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and toremifene
| Article | Year |
|---|---|
Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Antineoplastic Agents; Estrogen Antagonists; Female; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Receptors, Estrogen; Tamoxifen; Toremifene; Uterus | 1990 |
Antitumor effects of combination toremifene and medroxyprogesterone acetate (MPA) in vitro and in vivo.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Estrogen Antagonists; Female; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Toremifene; Tumor Cells, Cultured | 1990 |
Additive and synergistic antitumor effects with toremifene and interferons.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; Drug Interactions; Drug Synergism; Estrogen Antagonists; Female; Humans; Interferon Type I; Interferon-gamma; Mammary Neoplasms, Animal; Rats; Tamoxifen; Time Factors; Toremifene; Tumor Cells, Cultured | 1990 |
Biochemical and pharmacological effects of toremifene metabolites.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Cell Division; Mammary Neoplasms, Experimental; Mice; Rats; Receptors, Estrogen; Tamoxifen; Toremifene; Tumor Cells, Cultured | 1990 |
Biodistribution and scintigraphy of 11C-toremifene in rats bearing DMBA-induced mammary carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Chemical Phenomena; Chemistry; Estrogen Antagonists; Female; Mammary Neoplasms, Experimental; Rats; Tamoxifen; Tissue Distribution; Tomography, Emission-Computed; Toremifene | 1989 |
Expression of the c-Ha-ras and neu oncogenes in DMBA-induced, anti-estrogen-treated rat mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Deoxyribonucleases, Type II Site-Specific; DNA, Neoplasm; Estrogen Antagonists; Gene Expression Regulation; Genes, ras; Mammary Neoplasms, Experimental; Oncogenes; Rats; Rats, Inbred Strains; RNA, Neoplasm; Tamoxifen; Toremifene | 1988 |
Antitumor actions of toremifene in the 7,12-dimethylbenzanthracene (DMBA)-induced rat mammary tumor model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Estrogen Antagonists; Mammary Neoplasms, Experimental; Progesterone; Rats; Rats, Inbred Strains; Tamoxifen; Toremifene | 1988 |
Cell proliferation in dimethylbenz(A)anthracene(DMBA)-induced rat mammary carcinoma treated with antiestrogen toremifene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Division; Female; Flow Cytometry; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Toremifene | 1995 |
Evaluating the response to antioestrogen toremifene treatment in DMBA induced rat mammary carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Epithelium; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mitotic Index; Rats; Rats, Sprague-Dawley; Stromal Cells; Toremifene | 1994 |
Cell loss in dimethylbenz(a)anthracene-induced rat mammary carcinoma treated with toremifene and ovariectomy.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Division; Female; Mammary Neoplasms, Experimental; Microscopy, Electron; Ovariectomy; Rats; Rats, Sprague-Dawley; Toremifene | 1994 |
Aryl hydrocarbon hydroxylase activity in chemically induced and toremifene-treated mammary tumors in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Aryl Hydrocarbon Hydroxylases; Drug Screening Assays, Antitumor; Female; Liver; Lung; Mammary Glands, Animal; Mammary Neoplasms, Experimental; NADPH-Ferrihemoprotein Reductase; Rats; Rats, Sprague-Dawley; Toremifene; Uterus | 1994 |
Mitotic activity, apoptosis and TRPM-2 mRNA expression in DMBA-induced rat mammary carcinoma treated with anti-estrogen toremifene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Blotting, Northern; Clusterin; Glycoproteins; Mammary Neoplasms, Experimental; Mitosis; Molecular Chaperones; Rats; RNA, Messenger; Toremifene | 1993 |
Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bone and Bones; Breast Neoplasms; Cholesterol; Estrogen Antagonists; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Organ Size; Osteoporosis; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Reference Values; Tamoxifen; Toremifene; Transplantation, Heterologous; Tumor Cells, Cultured; Uterus | 2000 |